Literature DB >> 31759225

Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?

Sherri A McFarland1, Arkady Mandel2, Roger Dumoulin-White2, Gilles Gasser3.   

Abstract

Photodynamic therapy (PDT) is an approved medical technique to treat certain forms of cancer. It has been used to complement traditional anticancer modalities such as surgery, chemotherapy or radiotherapy, and in certain cases, to replace these treatments. One critical parameter of PDT is the photosensitizer (PS); historically, a purely organic macrocyclic tetrapyrrole-based structure. This short review surveys two recent clinical examples of metal complexes, namely TOOKAD®-Soluble and TLD-1433, which have ideal photophysical properties to act as PDT PSs. We highlight the important role played by the metal ions in the PS for PDT activity.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioinorganic chemistry; Medicinal inorganic chemistry; Metals in medicine; Photodynamic therapy; Photosensitizer

Mesh:

Substances:

Year:  2019        PMID: 31759225      PMCID: PMC7237330          DOI: 10.1016/j.cbpa.2019.10.004

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  25 in total

Review 1.  Photodynamic therapy for focal ablation of the prostate.

Authors:  Nimalan Arumainayagam; C M Moore; Hashim U Ahmed; M Emberton
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

Review 2.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

3.  Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Authors:  Abdel-Rahmène Azzouzi; Sébastien Vincendeau; Eric Barret; Antony Cicco; François Kleinclauss; Henk G van der Poel; Christian G Stief; Jens Rassweiler; Georg Salomon; Eduardo Solsona; Antonio Alcaraz; Teuvo T Tammela; Derek J Rosario; Francisco Gomez-Veiga; Göran Ahlgren; Fawzi Benzaghou; Bertrand Gaillac; Billy Amzal; Frans M J Debruyne; Gaëlle Fromont; Christian Gratzke; Mark Emberton
Journal:  Lancet Oncol       Date:  2016-12-20       Impact factor: 41.316

Review 4.  Photodynamic therapy: oncologic horizons.

Authors:  Ron R Allison
Journal:  Future Oncol       Date:  2014-01       Impact factor: 3.404

5.  Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability.

Authors:  Sonja Hatz; John D C Lambert; Peter R Ogilby
Journal:  Photochem Photobiol Sci       Date:  2007-07-30       Impact factor: 3.982

6.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

Review 7.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects.

Authors:  K Plaetzer; B Krammer; J Berlanda; F Berr; T Kiesslich
Journal:  Lasers Med Sci       Date:  2008-02-05       Impact factor: 3.161

8.  The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen.

Authors:  J Moan; K Berg
Journal:  Photochem Photobiol       Date:  1991-04       Impact factor: 3.421

9.  Photodynamic therapy and the development of metal-based photosensitisers.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Met Based Drugs       Date:  2008

Review 10.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02
View more
  39 in total

Review 1.  Critical discussion of the applications of metal complexes for 2-photon photodynamic therapy.

Authors:  Johannes Karges; Hui Chao; Gilles Gasser
Journal:  J Biol Inorg Chem       Date:  2020-11-04       Impact factor: 3.358

2.  Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy.

Authors:  Avinash Chettri; Houston D Cole; John A Roque Iii; Kilian R A Schneider; Tingxiang Yang; Colin G Cameron; Sherri A McFarland; Benjamin Dietzek-Ivanšić
Journal:  J Phys Chem A       Date:  2022-02-18       Impact factor: 2.781

3.  Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Authors:  Deborah A Smithen; Susan Monro; Mitch Pinto; John Roque; Roberto M Diaz-Rodriguez; Huimin Yin; Colin G Cameron; Alison Thompson; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-10-06       Impact factor: 9.825

4.  Singlet Oxygen Formation vs Photodissociation for Light-Responsive Protic Ruthenium Anticancer Compounds: The Oxygenated Substituent Determines Which Pathway Dominates.

Authors:  Fengrui Qu; Robert W Lamb; Colin G Cameron; Seungjo Park; Olaitan Oladipupo; Jessica L Gray; Yifei Xu; Houston D Cole; Marco Bonizzoni; Yonghyun Kim; Sherri A McFarland; Charles Edwin Webster; Elizabeth T Papish
Journal:  Inorg Chem       Date:  2021-02-03       Impact factor: 5.165

5.  cis-Locked Ru(II)-DMSO Precursors for the Microwave-Assisted Synthesis of Bis-Heteroleptic Polypyridyl Compounds.

Authors:  Alessio Vidal; Rudy Calligaro; Gilles Gasser; Roger Alberto; Gabriele Balducci; Enzo Alessio
Journal:  Inorg Chem       Date:  2021-04-28       Impact factor: 5.165

6.  Ruthenium-initiated polymerization of lactide: a route to remarkable cellular uptake for photodynamic therapy of cancer.

Authors:  Nancy Soliman; Luke K McKenzie; Johannes Karges; Emilie Bertrand; Mickaël Tharaud; Marta Jakubaszek; Vincent Guérineau; Bruno Goud; Marcel Hollenstein; Gilles Gasser; Christophe M Thomas
Journal:  Chem Sci       Date:  2020-01-30       Impact factor: 9.825

7.  Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles.

Authors:  Mariia R Mollaeva; Elena Nikolskaya; Veronika Beganovskaya; Maria Sokol; Margarita Chirkina; Sergey Obydennyi; Dmitry Belykh; Olga Startseva; Murad D Mollaev; Nikita Yabbarov
Journal:  Antioxidants (Basel)       Date:  2021-12-13

8.  NIR-Absorbing RuII Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.

Authors:  Liubov M Lifshits; John A Roque; Houston D Cole; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  Chembiochem       Date:  2020-09-25       Impact factor: 3.164

9.  It Takes Three to Tango - the length of the oligothiophene determines the nature of the long-lived excited state and the resulting photocytotoxicity of a Ru(II) photodrug.

Authors:  Avinash Chettri; John A Roque; Kilian R A Schneider; Houston D Cole; Colin G Cameron; Sherri A McFarland; Benjamin Dietzek
Journal:  ChemPhotoChem       Date:  2021-01-19

Review 10.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.